A Case-Control Study on Risk Factors of Osteoporosis in Patients with Crohn's Disease

Author(s):

H. Vahedi , S. Momtahen , G. Olfati , A. Abtahi , S. Hosseini , A. S. Kazzazi , H. Khademi , S. Rashtak , R. Khaleghnejad , T. Tabrizian , Z. Hamidi , M. Nouraie , F. Malekzadeh , S. Merat , S. Nasseri , Moghaddam , R. Sotoudehmanesh , B. Larijani

Message:
Abstract:
Background
Osteoporosis has been frequently reported in patients with inflammatory bowel diseases, especially Crohn’s disease.
Methods
All consecutive Crohn’s disease patients who attended the GI Clinics at Shariati Hospital, Tehran, Iran, from 2004 to 2007 were evaluated. A BMD-DEXA assessment was performed for all patients. Among those patients diagnosed with osteoporosis (T score ≤ -2.5 SD), 30 patients were chosen as study cases. Of those who were not diagnosed with osteoporosis, 85 were chosen as the control group. A thorough patient history including: age, sex, body mass index, cumulative corticosteroid dose, previous fracture, history of bowel resection, site and duration of disease, smoking and consumption of calcium and vitamin D, was taken from all patients through a face-to-face interview. Independent sample Student’s t-test, Chi-square, and logistic regression analyses were used for data analysis.
Results
In this study, a multivariable modeling technique revealed a higher osteoporosis risk in those who had a lower body mass index, previous fractures and longer disease duration. A cumulative corticosteroid dose of 10 – 35 g provided the highest osteoporosis risk. Age, sex, bowel resection, site of disease, smoking and consumption of calcium and vitamin D did not show any relationship with osteoporosis.
Conclusion
The highest osteoporosis risk was seen in patients with a cumulative 10 – 35 g corticosteroid dose and could be due to both steroid inefficiency in reducing Crohn’s disease inflammation as well as the cumulative drug dose and it’s adverse effect on patients.
Language:
English
Published:
Archives of Iranian Medicine, Volume:12 Issue: 6, Nov 2009
Page:
570
https://magiran.com/p672743  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
اطلاعات بیشتر
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!
More information